• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃旁路手术增加循环胆汁酸并激活肝法尼醇 X 受体 (FXR),但需要完整的过氧化物酶体增殖物激活受体 α (PPARα) 信号来显著减少肝脏脂肪含量。

Gastric Bypass Increases Circulating Bile Acids and Activates Hepatic Farnesoid X Receptor (FXR) but Requires Intact Peroxisome Proliferator Activator Receptor Alpha (PPARα) Signaling to Significantly Reduce Liver Fat Content.

机构信息

Division of Bariatric and Gastrointestinal Surgery, Department of Surgery, Virginia Commonwealth University, 1200 E. Broad Street, Richmond, VA, USA.

Division of Gastrointestinal Surgery, Hospital de Clínicas de Porto Alegre, 2350 Ramiro Barcelos Street, Porto Alegre, RS, Brazil.

出版信息

J Gastrointest Surg. 2021 Apr;25(4):871-879. doi: 10.1007/s11605-021-04908-3. Epub 2021 Feb 8.

DOI:10.1007/s11605-021-04908-3
PMID:33555523
Abstract

BACKGROUND

We interrogate effects of gastric bypass (RYGB), compared with a low-calorie diet, on bile acid (BA), liver fat, and FXR, PPARα, and targets in rats with obesity and non-alcoholic fatty liver disease (NAFLD).

METHODS

Male Wistar rats received a high-fat diet (obese/NAFLD, n=24) or standard chow (lean, n=8) for 12 weeks. Obese/NAFLD rats had RYGB (n=11), sham operation pair-fed to RYGB (pair-fed sham, n=8), or sham operation (sham, n=5). Lean rats had sham operation (lean sham, n=8). Post-operatively, five RYGB rats received PPARα antagonist GW6417. Sacrifice occurred at 7 weeks. We measured weight changes, fasting total plasma BA, and liver % steatosis, triglycerides, and mRNA expression of the nuclear receptors FXR, PPARα, and their targets SHP and CPT-I.

RESULTS

At sacrifice, obese sham was heavier (p<0.01) than all other groups that had lost similar weight loss. Obese sham had lower BA levels and lower hepatic FXR, SHP, and CPT-I mRNA expression than lean sham (P<0.05, for all comparisons). RYGB had increased BA levels compared with obese and pair-fed sham (P<0.05, for both), while pair-fed sham had BA levels, similar to obese sham. Compared with pair-fed sham, RYGB animals had increased liver FXR and PPARα expression and signaling (P<0.05). Percentage of steatosis was lower in RYGB and lean sham, relative to obese and pair-fed sham (P<0.05, for all comparisons). PPARα inhibition after RYGB resulted in similar weight loss but higher liver triglyceride content (P=0.01) compared with RYGB alone.

CONCLUSIONS

RYGB led to greater liver fat loss than low-calorie diet, an effect associated to increased fasting BA levels and increased expression of modulators of liver fat oxidation, FXR, and PPARα. However, intact PPARα signaling was necessary for resolution of NAFLD after RYGB.

摘要

背景

我们研究了胃旁路手术(RYGB)与低热量饮食相比,对胆汁酸(BA)、肝脂肪和 FXR、PPARα 以及肥胖和非酒精性脂肪性肝病(NAFLD)大鼠靶标的影响。

方法

雄性 Wistar 大鼠接受高脂肪饮食(肥胖/NAFLD,n=24)或标准饲料(瘦,n=8)喂养 12 周。肥胖/NAFLD 大鼠接受 RYGB(n=11)、RYGB 配对喂养(配对喂养假手术,n=8)或假手术(假手术,n=5)。瘦大鼠接受假手术(瘦假手术,n=8)。手术后,5 只 RYGB 大鼠接受 PPARα 拮抗剂 GW6417 治疗。7 周后处死大鼠。我们测量体重变化、空腹总血浆 BA 以及肝脂肪含量、甘油三酯和核受体 FXR、PPARα 及其靶基因 SHP 和 CPT-I 的 mRNA 表达。

结果

在处死时,肥胖假手术组大鼠体重高于所有其他组(p<0.01),但这些组的体重减轻程度相似。与瘦假手术组相比,肥胖假手术组 BA 水平较低,肝 FXR、SHP 和 CPT-I mRNA 表达水平较低(P<0.05,所有比较)。与肥胖和配对喂养假手术组相比,RYGB 组 BA 水平升高(P<0.05,两者均升高),而配对喂养假手术组的 BA 水平与肥胖假手术组相似。与配对喂养假手术组相比,RYGB 动物肝 FXR 和 PPARα 表达和信号增强(P<0.05)。与肥胖和配对喂养假手术组相比,RYGB 和瘦假手术组的肝脂肪变性百分比降低(P<0.05,所有比较)。与单独 RYGB 相比,RYGB 后抑制 PPARα 导致相似的体重减轻,但肝甘油三酯含量增加(P=0.01)。

结论

RYGB 导致的肝脂肪丢失多于低热量饮食,这种作用与空腹 BA 水平升高以及肝脂肪氧化调节因子 FXR 和 PPARα 表达增加有关。然而,RYGB 后完整的 PPARα 信号传导对于 NAFLD 的恢复是必要的。

相似文献

1
Gastric Bypass Increases Circulating Bile Acids and Activates Hepatic Farnesoid X Receptor (FXR) but Requires Intact Peroxisome Proliferator Activator Receptor Alpha (PPARα) Signaling to Significantly Reduce Liver Fat Content.胃旁路手术增加循环胆汁酸并激活肝法尼醇 X 受体 (FXR),但需要完整的过氧化物酶体增殖物激活受体 α (PPARα) 信号来显著减少肝脏脂肪含量。
J Gastrointest Surg. 2021 Apr;25(4):871-879. doi: 10.1007/s11605-021-04908-3. Epub 2021 Feb 8.
2
Concomitant PPARα and FXR Activation as a Putative Mechanism of NASH Improvement after Gastric Bypass Surgery: a GEO Datasets Analysis.胃旁路手术后非酒精性脂肪性肝炎改善的潜在机制:PPARα 和 FXR 同时激活:一项 GEO 数据集分析。
J Gastrointest Surg. 2019 Jan;23(1):51-57. doi: 10.1007/s11605-018-3938-z. Epub 2018 Sep 11.
3
Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.Roux-en-Y 胃旁路手术通过增加血清胆汁酸水平和肝法尼醇 X 受体表达改善 2 型糖尿病大鼠模型的代谢状况。
Obes Surg. 2019 Sep;29(9):2912-2922. doi: 10.1007/s11695-019-03918-0.
4
Effects of Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in an Obese Rat Model.袖状胃切除术对肥胖大鼠模型非酒精性脂肪肝的影响。
Obes Surg. 2018 Jun;28(6):1532-1539. doi: 10.1007/s11695-017-3052-4.
5
Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress.胃旁路手术可预防高脂饮食诱导的非酒精性脂肪性肝病和肝脏内质网应激。
Acta Physiol (Oxf). 2016 Jun;217(2):141-51. doi: 10.1111/apha.12640. Epub 2015 Dec 29.
6
Pregnancy and lactation after Roux-en-Y gastric bypass worsen nonalcoholic fatty liver disease in obese rats and lead to differential programming of hepatic lipogenesis in offspring.肥胖大鼠 Roux-en-Y 胃旁路手术后妊娠和哺乳会加重非酒精性脂肪性肝病,并导致后代肝脏脂肪生成的差异编程。
J Dev Orig Health Dis. 2022 Apr;13(2):263-273. doi: 10.1017/S2040174421000271. Epub 2021 May 17.
7
Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.法尼酯X受体有助于饮食诱导肥胖小鼠行Roux-en-Y胃旁路手术后血糖控制的改善,且这种改善与体重无关。
Mol Metab. 2020 Jul;37:100980. doi: 10.1016/j.molmet.2020.100980. Epub 2020 Mar 19.
8
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.虾青素和安卡黄素作为天然 AMPK 激活剂,具有 PPARα 激动剂活性,可下调高脂饮食喂养的 C57BL/6 小鼠的非酒精性脂肪性肝炎。
Food Chem Toxicol. 2014 Feb;64:94-103. doi: 10.1016/j.fct.2013.11.015. Epub 2013 Nov 22.
9
Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway.薯蓣皂苷元通过肝 FXR-SHP-SREBP1C/PPARα/CD36 通路减轻非酒精性肝脂肪变性。
Eur J Pharmacol. 2023 Aug 5;952:175808. doi: 10.1016/j.ejphar.2023.175808. Epub 2023 May 30.
10
Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.三甲胺 N-氧化物通过调节胆汁酸代谢和抑制法尼醇 X 受体信号通路加重非酒精性脂肪性肝病中的肝脂肪变性。
Mol Nutr Food Res. 2019 Sep;63(17):e1900257. doi: 10.1002/mnfr.201900257. Epub 2019 May 22.

引用本文的文献

1
Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease.释放治疗潜力:探索新兴核受体之间的相互作用以对抗脂肪性肝病中的代谢功能障碍。
NPJ Metab Health Dis. 2024 Jul 3;2(1):13. doi: 10.1038/s44324-024-00013-6.
2
LZys1 modulates gut microbiota, diminishes ileal FXR-FGF15 signaling, and regulates hepatic function.LZys1调节肠道微生物群,减少回肠FXR-FGF15信号传导,并调节肝功能。
Microbiol Spectr. 2025 Jun 3;13(6):e0171624. doi: 10.1128/spectrum.01716-24. Epub 2025 Apr 17.
3
Differential effects of bariatric surgery and lifestyle interventions on plasma levels of Lp(a) and fatty acids.

本文引用的文献

1
NCBI GEO: archive for functional genomics data sets--update.NCBI GEO:功能基因组学数据集存档 - 更新。
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5. doi: 10.1093/nar/gks1193. Epub 2012 Nov 27.
减重手术和生活方式干预对脂蛋白(a)和脂肪酸血浆水平的影响差异。
Lipids Health Dis. 2022 Dec 28;21(1):145. doi: 10.1186/s12944-022-01756-1.
4
The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity.法尼醇 X 受体作为肝毒性的主调控因子。
Int J Mol Sci. 2022 Nov 12;23(22):13967. doi: 10.3390/ijms232213967.
5
Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia.减重手术后的葡萄糖代谢:对 T2DM 缓解和低血糖的影响。
Nat Rev Endocrinol. 2023 Mar;19(3):164-176. doi: 10.1038/s41574-022-00757-5. Epub 2022 Oct 26.
6
Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality.非酒精性脂肪性肝病及减肥手术后的肠道微生物群和微生物代谢产物:相关性与因果关系
Front Microbiol. 2022 Sep 20;13:1003755. doi: 10.3389/fmicb.2022.1003755. eCollection 2022.
7
Reversal of NAFLD After VSG Is Independent of Weight-Loss but RYGB Offers More Efficacy When Maintained on a High-Fat Diet.胃旁路手术后非酒精性脂肪性肝病的逆转独立于体重减轻,但在高脂肪饮食维持时,RYGB 提供更有效的疗效。
Obes Surg. 2022 Jun;32(6):2010-2022. doi: 10.1007/s11695-022-06053-5. Epub 2022 Apr 14.
8
Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review.非酒精性脂肪性肝病患者及减肥手术后的肠道微生物群与代谢产物:综述
Metabolites. 2021 May 31;11(6):353. doi: 10.3390/metabo11060353.